Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1

被引:386
作者
Sanders, RW
Vesanen, M
Schuelke, N
Master, A
Schiffner, L
Kalyanaraman, R
Paluch, M
Berkhout, B
Maddon, PJ
Olson, WC
Lu, M
Moore, JP
机构
[1] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA
[2] Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA
[3] Univ Amsterdam, Acad Med Ctr, Dept Human Retrovirol, NL-1105 AZ Amsterdam, Netherlands
[4] Progen Pharmaceut, Tarrytown, NY 10591 USA
关键词
D O I
10.1128/JVI.76.17.8875-8889.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The envelope glycoprotein (Env) complex of human immunodeficiency virus type I has evolved a structure that is minimally immunogenic while retaining its natural function of receptor-mediated virus-cell fusion. The Env complex is trimeric; its six individual subunits (three gp120 and three gp41 subunits) are associated by relatively weak, noncovalent interactions. The induction of neutralizing antibodies after vaccination with individual Env subunits has proven very difficult, probably because they are inadequate mimics of the native complex. Our hypothesis is that a stable form of the Env complex, perhaps with additional modifications to rationally alter its antigenic structure, may be a better immunogen than the individual subunits. A soluble form of Env, SOS gp140, can be made that has gp120 stably linked to the gp41 ectodomain by an intermolecular disulfide bond. This protein is fully cleaved at the proteolysis site between gp120 and gp41. However, the gp41-gp41 interactions in SOS gp140 are too weak to maintain the protein in a trimeric configuration. Consequently, purified SOS gp140 is a monomer (N. Schulke, M. S. Vesanen, R. W. Sanders, P. Zhu, D. J. Anselma, A. R. Villa, P. W. H. I. Parren, J. M. Binley, K. H. Roux, P. J. Maddon, J. P. Moore, and W. C. Olson, J. Virol. 76:7760-7776, 2002). Here we describe modifications of SOS gp140 that increase its trimer stability. A variant SOS gp140, designated SOSIP gp140, contains an isoleucine-to-proline substitution at position 559 in the N-terminal heptad repeat region of gp41. This protein is fully cleaved, has favorable antigenic properties, and is predominantly trimeric. SOSIP gp140 trimers are noncovalently associated and can be partially purified by gel filtration chromatography. These gp140 trimers are dissociated into monomers by anionic detergents or heat but are relatively resistant to nonionic detergents, high salt concentrations, or exposure to a mildly acidic pH. SOSIP gp140 should be a useful reagent for structural and immunogenicity studies.
引用
收藏
页码:8875 / 8889
页数:15
相关论文
共 106 条
[1]   EXPRESSION AND CHARACTERIZATION OF CD4-IGG(2), A NOVEL HETEROTETRAMER THAT NEUTRALIZES PRIMARY HIV TYPE-1 ISOLATES [J].
ALLAWAY, GP ;
DAVISBRUNO, KL ;
BEAUDRY, GA ;
GARCIA, EB ;
WONG, EL ;
RYDER, AM ;
HASEL, KW ;
GAUDUIN, MC ;
KOUP, RA ;
MCDOUGAL, JS ;
MADDON, PJ .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (05) :533-539
[2]   The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region [J].
Barnet, SW ;
Lu, S ;
Srivastava, I ;
Cherpelis, S ;
Gettie, A ;
Blanchard, J ;
Wang, S ;
Mboudjeka, I ;
Leung, L ;
Lian, Y ;
Fong, A ;
Buckner, C ;
Ly, A ;
Hilt, S ;
Ulmer, J ;
Wild, CT ;
Mascola, JR ;
Stamatatos, L .
JOURNAL OF VIROLOGY, 2001, 75 (12) :5526-5540
[3]   OLIGOMERIZATION OF THE HYDROPHOBIC HEPTAD REPEAT OF GP41 [J].
BERNSTEIN, HB ;
TUCKER, SP ;
KAR, SR ;
MCPHERSON, SA ;
MCPHERSON, DT ;
DUBAY, JW ;
LEBOWITZ, J ;
COMPANS, RW ;
HUNTER, E .
JOURNAL OF VIROLOGY, 1995, 69 (05) :2745-2750
[4]   Design of a novel peptide inhibitor of HIV fusion that disrupts the internal trimeric coiled-coil of gp41 [J].
Bewley, CA ;
Louis, JM ;
Ghirlando, R ;
Clore, GM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (16) :14238-14245
[5]   Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins [J].
Binley, JM ;
Sanders, RW ;
Master, A ;
Cayanan, CS ;
Wiley, CL ;
Schiffner, L ;
Travis, B ;
Kuhmann, S ;
Burton, DR ;
Hu, SL ;
Olson, WC ;
Moore, JP .
JOURNAL OF VIROLOGY, 2002, 76 (06) :2606-2616
[6]   A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure [J].
Binley, JM ;
Sanders, RW ;
Clas, B ;
Schuelke, N ;
Master, A ;
Guo, Y ;
Kajumo, F ;
Anselma, DJ ;
Maddon, PJ ;
Olson, WC ;
Moore, JP .
JOURNAL OF VIROLOGY, 2000, 74 (02) :627-643
[7]   Enhanced immunogenicity of a human immunodeficiency virus type 1 env DNA vaccine by manipulating N-glycosylation signals - Effects of elimination of the V3N306 glycan [J].
Bolmstedt, A ;
Hinkula, J ;
Rowcliffe, E ;
Biller, M ;
Wahren, B ;
Olofsson, S .
VACCINE, 2001, 20 (3-4) :397-405
[8]   STRUCTURE OF INFLUENZA HEMAGGLUTININ AT THE PH OF MEMBRANE-FUSION [J].
BULLOUGH, PA ;
HUGHSON, FM ;
SKEHEL, JJ ;
WILEY, DC .
NATURE, 1994, 371 (6492) :37-43
[9]   Vaccines and the induction of functional antibodies: Time to look beyond the molecules of natural infection? [J].
Burton, DR ;
Parren, PWHI .
NATURE MEDICINE, 2000, 6 (02) :123-125
[10]   Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41 [J].
Caffrey, M ;
Cai, ML ;
Kaufman, J ;
Stahl, SJ ;
Wingfield, PT ;
Covell, DG ;
Gronenborn, AM ;
Clore, GM .
EMBO JOURNAL, 1998, 17 (16) :4572-4584